Evogene - מכפיל מחיר להכנסות עתידי EVGN
International partnerships of Evogene Ltd. (EVGN) confirm investor confidence in management. Cloud AI infrastructure in the US and Israel ensures computational reliability, although fierce patent battles in the agrobio sector create risks. The forward P/S ratio visualizes these market expectations, and 3.80 shows the current value of the metric, helping to identify the trend reversal point.
פילוחים אנליטיים ודוחות נתונים של חברת evogene.com (EVGN)
Evogene Ltd. is currently scaling its billing software systems and testing AI modules for medicine, which necessitates a precise assessment of future cash flows. The indicator provided on the GURU.Markets platform compares current market capitalization with projected revenue, allowing investors to evaluate business resilience against market expectations via the expected P/S valuation to minimize risks in the event of a guidance miss.
